---
title: "Eloxx Pharmaceuticals, Inc. (ELOX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ELOX.US.md"
symbol: "ELOX.US"
name: "Eloxx Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
---

# Eloxx Pharmaceuticals, Inc. (ELOX.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.eloxxpharma.com](https://www.eloxxpharma.com) |

## Company Profile

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of RNA-modulating drugs in the United States. The company develops ELX-02, which is in phase II clinical trial for the treatment of nonsense mutation alport syndrome; ZKN013, which is in investigation...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-02-12T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/ELOX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ELOX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ELOX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.